Impact of autoclave sterilization on the activity and structure of formulated heparin. - Wikidata - wikimedia - TriplyDB

Impact of autoclave sterilization on the activity and structure of formulated heparin.

Impact of autoclave sterilization on the activity and structure of formulated heparin.

http://www.wikidata.org/entity/Q35185938

about

Engineering of routes to heparin and related polysaccharides Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery.Structural characterization of heparins from different commercial sources Preparation and characterization of heparin hexasaccharide library with N-unsubstituted glucosamine residues.Structural characterization of pharmaceutical heparins prepared from different animal tissues.Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides.Heparin stability by determining unsubstituted amino groups using hydrophilic interaction chromatography mass spectrometry

P2860

Q27013519-1EF3AD7F-687C-45B0-8693-BBF8308BE97B Q35078253-F99710C2-CDE0-46DE-BEC9-CE9E7E40CF44 Q35488687-6E2FD509-6782-45C0-AA12-A9B0103E9AD3 Q35746811-29562B80-1B17-4EB8-960F-A7A0F8F67D6A Q37400253-054D4535-E2C3-476B-A596-C3284312B5B1 Q37721780-6A5BD3A3-9927-4F11-9A87-E847CB245F33 Q41442587-B75D8DE0-28CB-42A9-A136-92D79E304108 Q42543798-A1967938-CF76-4EC0-AA09-0F83112ADD98

P2860

Impact of autoclave sterilization on the activity and structure of formulated heparin.

http://www.wikidata.org/entity/Q35185938

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@ast

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@en

type

label

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@ast

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@en

prefLabel

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@ast

Impact of autoclave sterilization on the activity and structure of formulated heparin.

@en

P1433

Q35185938-11EA2822-D01C-4FF7-ADBE-42BB2DC1B4F4

P1476

Q35185938-9FA948A2-38C8-4818-874C-F188F257610E

P2093

Q35185938-198143A1-6C15-405F-8BD8-D580EC687575

Q35185938-6D391268-A879-42C0-A981-5C70BED80AE0

Q35185938-7AFF1822-86A5-4459-BBA2-3E43072D30C9

Q35185938-D4A9E441-D193-4370-B808-11F79567751C

Q35185938-DEEDEDC9-54D2-40D4-8415-4EC0D1F2CC1F

Q35185938-DFA98B7C-ABB2-495B-86BC-04472839D6BD

P2860

Q35185938-031ED86D-F3AD-4CD8-9325-A08CAD9A8328

Q35185938-0D7DE6BA-20E2-4005-BF01-4895B84147D7

Q35185938-2E5CCA7F-5944-427B-8C9F-F64AFCEC7010

Q35185938-3D0C351D-CB1A-4591-8FDD-983D16B48EC0

Q35185938-6724BAB4-4C9C-4312-9340-7D668C5357EB

Q35185938-6CD4049C-E8E8-486E-936A-68933B5FB160

Q35185938-89384876-2E0D-4BC8-88CF-1FDD69853371

Q35185938-B1386E0A-D341-4714-89C3-505C6AD12A34

Q35185938-B7083A4E-A3E5-43C7-8C35-54BD5E16810E

Q35185938-FD4A63A8-121E-417A-B2B9-857211A16B68

P304

Q35185938-04C32AE1-B9D6-4521-A04B-C8DA902D4B70

P31

Q35185938-C70BCE6E-3FE0-45B3-86E1-2DEF6052AD4F

P356

Q35185938-939190FB-E7D1-4C16-8901-866C109B43D6

P407

Q35185938-CC5F3C80-5D33-4F3F-A3B4-0EFA3CE5D399

P433

Q35185938-C8310D63-FAF8-4B2D-A9AB-7CC34073158D

P478

Q35185938-21C4DC4F-4D1E-46F5-9AD1-4A3C4A004BD4

P50

Q35185938-66FD5274-BEB9-40DF-B00F-B057AB6549D9

Q35185938-8F20119D-F83C-4801-A164-B18FED1683ED

P577

Q35185938-0A432D5E-D57B-42AC-BA06-325C779EBDFA

P5875

Q35185938-0307AF47-C3CD-4BC8-AC1B-BC95FCBB09A1

P698

Q35185938-6827B9D2-0A23-46B8-8A9E-AA48F450586B

P932

Q35185938-630062D8-C531-493D-A72A-B9C5C69DE6BC

P356

P1433

Journal of Pharmaceutical Sciences

P1476

Impact of autoclave sterilization on the activity and structure of formulated heparin

@en

P2093

Amanda Weyers

http://www.w3.org/2001/XMLSchema#string

Bo Yang

http://www.w3.org/2001/XMLSchema#string

Fuming Zhang

http://www.w3.org/2001/XMLSchema#string

Julie M Beaudet

http://www.w3.org/2001/XMLSchema#string

Majde Takieddin

http://www.w3.org/2001/XMLSchema#string

Robert J Linhardt

http://www.w3.org/2001/XMLSchema#string

P2860

Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III

Production and chemical processing of low molecular weight heparins.

Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.

Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.

Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin.

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry.

P304

3396-3404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JPS.22527

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Kemal Solakyildirim

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50421222

http://www.w3.org/2001/XMLSchema#string

P698

21416466

http://www.w3.org/2001/XMLSchema#string

P932

3163591

http://www.w3.org/2001/XMLSchema#string